Journal article
Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers.
- Abstract:
- RATIONALE: There is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of information that is strongly linked to anxiety and depression, and influences the neuroendocrine stress response. We have recently demonstrated that prebiotics (soluble fibres that augment the growth of indigenous microbiota) have significant neurobiological effects in rats, but their action in humans has not been reported. OBJECTIVES: The present study explored the effects of two prebiotics on the secretion of the stress hormone, cortisol and emotional processing in healthy volunteers. METHODS: Forty-five healthy volunteers received one of two prebiotics (fructooligosaccharides, FOS, or Bimuno®-galactooligosaccharides, B-GOS) or a placebo (maltodextrin) daily for 3 weeks. The salivary cortisol awakening response was sampled before and after prebiotic/placebo administration. On the final day of treatment, participants completed a computerised task battery assessing the processing of emotionally salient information. RESULTS: The salivary cortisol awakening response was significantly lower after B-GOS intake compared with placebo. Participants also showed decreased attentional vigilance to negative versus positive information in a dot-probe task after B-GOS compared to placebo intake. No effects were found after the administration of FOS. CONCLUSION: The suppression of the neuroendocrine stress response and the increase in the processing of positive versus negative attentional vigilance in subjects supplemented with B-GOS are consistent with previous findings of endocrine and anxiolytic effects of microbiota proliferation. Further studies are therefore needed to test the utility of B-GOS supplementation in the treatment of stress-related disorders.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 455.5KB, Terms of use)
-
- Publisher copy:
- 10.1007/s00213-014-3810-0
Authors
- Publisher:
- Springer Berlin Heidelberg
- Journal:
- Psychopharmacology More from this journal
- Volume:
- 232
- Issue:
- 10
- Pages:
- 1793-1801
- Publication date:
- 2014-12-01
- DOI:
- EISSN:
-
1432-2072
- ISSN:
-
0033-3158
- Language:
-
English
- Keywords:
- Pubs id:
-
492972
- UUID:
-
uuid:1f11f684-93ac-476b-b8e4-c117b5badb56
- Local pid:
-
pubs:492972
- Source identifiers:
-
492972
- Deposit date:
-
2014-12-19
- ARK identifier:
Terms of use
- Copyright holder:
- Schmidt et al
- Copyright date:
- 2014
- Notes:
-
Copyright © The Author(s) 2014. This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record